abstract |
The present invention provides methods of preparing substituted 2-(pyridin-2-ylamino)-pirido[2,3-d]pyrimidin-7-ones (formula 1), n n n n n n n n n n useful in treating cell proliferative disorders, or a pharmaceutically acceptable salt thereof. |